Company: PBH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001295947-25-000039
Chunk: 15

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 2
Chunk 15
---
 expenses was primarily due to increases in professional fees and acquisition costs.

Depreciation and Amortization

Depreciation and amortization expenses were $5.2 million for the three months ended September 30, 2025 and $5.6 million for the three months ended September 30, 2024.  The decrease in depreciation and amortization expenses was primarily due to a decrease in amortization expense due to impairment charges taken on certain finite-lived brands in fiscal 2025, as well as certain intangible assets being fully amortized during fiscal 2025.

Interest Expense, Net

Interest expense, net was $10.0 million during the three months ended September 30, 2025 versus $12.3 million during the three months ended September 30, 2024.  The average indebtedness decreased to $1.0 billion during the three months ended September 30, 2025 from $1.1 billion during the three months ended September 30, 2024.  The average cost of borrowing decreased to 4.5% for the three months ended September 30, 2025 from 4.7% for the three months ended September 30, 2024.

Income Taxes

The provision for income taxes during the three months ended September 30, 2025 was $26.9 million versus $17.3 million during the three months ended September 30, 2024.  The effective tax rate during the three months ended September 30, 2025 was 38.9% versus 24.1% during the three months ended September 30, 2024.  The increase in the effective tax rate for the three months ended September 30, 2025, compared to the three months ended September 30, 2024 was primarily due to establishing a taxable presence in a new state.

25

Results of Operations 

Six Months Ended September 30, 2025 compared to the Six Months Ended September 30, 2024

Total Segment Revenues

The following table represents total revenue by segment, including product groups, for the six months ended September 30, 2025 and 2024.

Six Months Ended September 30,Increase (Decrease)(In thousands)2025%2024%Amount%North American OTC HealthcareAnalgesics$54,490 10.4 $54,158 9.8 $332 0.6 Cough & Cold33,